The present invention provides pharmaceutical formulations comprising a human antibody that specifically binds to human interleukin-4 receptor (hlL-4R). The formulations may contain, in addition to an anti-hlL-4R antibody, at least one amino acid, at least one sugar, or at least one non-ionic surfactant. The pharmaceutical formulations of the present invention exhibit a substantial degree of antibody stability after storage for several months.本発明は、ヒトインターロイキン－４受容体（ｈＩＬ－４Ｒ）へ特異的に結合するヒト抗体を含む薬学的製剤を提供する。製剤は、抗ｈＩＬ－４Ｒ抗体に加えて、少なくとも１つのアミノ酸、少なくとも１つの糖、又は少なくとも１つの非イオン性界面活性剤を含有し得る。本発明の薬学的製剤は、数ヶ月間の保存後に実質的な程度の抗体安定性を示す。
